G Bianchini, C De Angelis… - Nature reviews …, 2022 - pubmed.ncbi.nlm.nih.gov
Tumour heterogeneity and a long-standing paucity of effective therapies other than chemotherapy have contributed to triple-negative breast cancer (TNBC) being the subtype …
G Bianchini, C De Angelis, L Licata… - Nature reviews. Clinical …, 2021 - europepmc.org
Tumour heterogeneity and a long-standing paucity of effective therapies other than chemotherapy have contributed to triple-negative breast cancer (TNBC) being the subtype …
G Bianchini, C De Angelis, L Licata… - Nature Reviews Clinical …, 2021 - cir.nii.ac.jp
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
G Bianchini, C De Angelis, L Licata… - NATURE REVIEWS …, 2022 - iris.unina.it
Tumour heterogeneity and a long-standing paucity of effective therapies other than chemotherapy have contributed to triple-negative breast cancer (TNBC) being the subtype …